HEADER HYDROLASE 19-JAN-10 3LFY TITLE CTD OF TAROCYSTATIN IN COMPLEX WITH PAPAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PAPAIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: PAPAIN DOMAIN; COMPND 5 SYNONYM: PAPAYA PROTEINASE I, PPI; COMPND 6 EC: 3.4.22.2 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CARICA PAPAYA; SOURCE 3 ORGANISM_COMMON: MAMON; SOURCE 4 ORGANISM_TAXID: 3649; SOURCE 5 OTHER_DETAILS: PAPAIN WAS PURCHASED FROM SIGMA CO. FOR CO- SOURCE 6 CRYSTALLIZATION. KEYWDS CYSTATIN, TAROCYSTATIN, CECPI, PAPAIN, PHYTOCYSTATIN, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.H.CHU,K.L.LIU,K.W.YEH,Y.S.CHENG REVDAT 4 22-NOV-23 3LFY 1 REMARK REVDAT 3 01-NOV-23 3LFY 1 REMARK REVDAT 2 18-NOV-20 3LFY 1 JRNL REMARK LINK REVDAT 1 21-JUL-10 3LFY 0 JRNL AUTH M.H.CHU,K.L.LIU,H.Y.WU,K.W.YEH,Y.S.CHENG JRNL TITL CRYSTAL STRUCTURE OF TAROCYSTATIN-PAPAIN COMPLEX: JRNL TITL 2 IMPLICATIONS FOR THE INHIBITION PROPERTY OF GROUP-2 JRNL TITL 3 PHYTOCYSTATINS. JRNL REF PLANTA V. 234 243 2011 JRNL REFN ISSN 0032-0935 JRNL PMID 21416241 JRNL DOI 10.1007/S00425-011-1398-8 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 211835.050 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.3 REMARK 3 NUMBER OF REFLECTIONS : 14897 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1476 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1852 REMARK 3 BIN R VALUE (WORKING SET) : 0.3710 REMARK 3 BIN FREE R VALUE : 0.4480 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 226 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3316 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 171 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.68000 REMARK 3 B22 (A**2) : 14.68000 REMARK 3 B33 (A**2) : -29.36000 REMARK 3 B12 (A**2) : 14.44000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.54 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.47 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.67 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.280 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.150 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.880 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.850 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 58.50 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3LFY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1000057229. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13C1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97315 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17482 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.560 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 45.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.51700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.080 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1PPN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 7.5, 70% V/V MPD, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.95667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 133.91333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 47 CD GLU A 47 OE2 0.082 REMARK 500 GLU A 118 CD GLU A 118 OE2 0.079 REMARK 500 GLU A 135 CD GLU A 135 OE2 0.074 REMARK 500 GLU C 47 CD GLU C 47 OE2 0.079 REMARK 500 GLU C 118 CD GLU C 118 OE2 0.082 REMARK 500 GLU C 135 CD GLU C 135 OE2 0.081 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 15 159.46 -48.72 REMARK 500 SER A 49 109.94 -56.50 REMARK 500 SER A 60 -159.48 -90.88 REMARK 500 TYR A 61 40.62 -140.29 REMARK 500 TYR A 78 -58.89 -137.41 REMARK 500 ARG A 93 -160.52 -109.85 REMARK 500 LYS A 156 59.97 -90.54 REMARK 500 ASP A 158 20.24 -149.64 REMARK 500 TRP C 7 -1.89 -57.41 REMARK 500 TYR C 78 -77.32 -138.21 REMARK 500 TYR C 86 62.17 -157.40 REMARK 500 ASP C 158 3.61 -157.91 REMARK 500 TYR C 170 -172.36 -174.90 REMARK 500 SER C 205 106.35 -167.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SER A 213 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ASN A 214 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SER C 213 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GLY C 214 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ASN C 215 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3IMA RELATED DB: PDB REMARK 900 TAROCYSTATIN IN COMPLEX WITH PAPAIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES A 213-214, C 213-215 WERE FROM C-TERMINAL OF CYSTEINE REMARK 999 PROTEINASE INHIBITOR (CECPI; SEQUENCE: REMARK 999 TPADLGVKRDAHEAEWLEIPTHDPVVQDAANHAVKSIQQRSNTLFPYELLEILHAKAKVLEDLAKIHL REMARK 999 LLKLKRGSREEKFKVEVHKNIEGTFHLNQMEQDHSDSGN; SOURCE: COCOCASIA REMARK 999 ESCULENTA; DATABASE: UNIPROTKB/TREMBL Q8L5J8; OVEREXPRESSED IN E. REMARK 999 COLI BL21(DE3); PLASMID NAME: PGEX-4T-1). THE C-TERMINAL DOMAIN OF REMARK 999 CSCPI WAS CO-CRYSTALLIZED WITH PAPAIN, BUT WAS DIGESTED BY PAPAIN. REMARK 999 ONLY 2 OR 3 RESIDUES REMAINED. DBREF 3LFY A 1 212 UNP P00784 PAPA1_CARPA 134 345 DBREF 3LFY C 1 212 UNP P00784 PAPA1_CARPA 134 345 SEQRES 1 A 212 ILE PRO GLU TYR VAL ASP TRP ARG GLN LYS GLY ALA VAL SEQRES 2 A 212 THR PRO VAL LYS ASN GLN GLY SER CYS GLY SER OCS TRP SEQRES 3 A 212 ALA PHE SER ALA VAL VAL THR ILE GLU GLY ILE ILE LYS SEQRES 4 A 212 ILE ARG THR GLY ASN LEU ASN GLU TYR SER GLU GLN GLU SEQRES 5 A 212 LEU LEU ASP CYS ASP ARG ARG SER TYR GLY CYS ASN GLY SEQRES 6 A 212 GLY TYR PRO TRP SER ALA LEU GLN LEU VAL ALA GLN TYR SEQRES 7 A 212 GLY ILE HIS TYR ARG ASN THR TYR PRO TYR GLU GLY VAL SEQRES 8 A 212 GLN ARG TYR CYS ARG SER ARG GLU LYS GLY PRO TYR ALA SEQRES 9 A 212 ALA LYS THR ASP GLY VAL ARG GLN VAL GLN PRO TYR ASN SEQRES 10 A 212 GLU GLY ALA LEU LEU TYR SER ILE ALA ASN GLN PRO VAL SEQRES 11 A 212 SER VAL VAL LEU GLU ALA ALA GLY LYS ASP PHE GLN LEU SEQRES 12 A 212 TYR ARG GLY GLY ILE PHE VAL GLY PRO CYS GLY ASN LYS SEQRES 13 A 212 VAL ASP HIS ALA VAL ALA ALA VAL GLY TYR GLY PRO ASN SEQRES 14 A 212 TYR ILE LEU ILE LYS ASN SER TRP GLY THR GLY TRP GLY SEQRES 15 A 212 GLU ASN GLY TYR ILE ARG ILE LYS ARG GLY THR GLY ASN SEQRES 16 A 212 SER TYR GLY VAL CYS GLY LEU TYR THR SER SER PHE TYR SEQRES 17 A 212 PRO VAL LYS ASN SEQRES 1 C 212 ILE PRO GLU TYR VAL ASP TRP ARG GLN LYS GLY ALA VAL SEQRES 2 C 212 THR PRO VAL LYS ASN GLN GLY SER CYS GLY SER OCS TRP SEQRES 3 C 212 ALA PHE SER ALA VAL VAL THR ILE GLU GLY ILE ILE LYS SEQRES 4 C 212 ILE ARG THR GLY ASN LEU ASN GLU TYR SER GLU GLN GLU SEQRES 5 C 212 LEU LEU ASP CYS ASP ARG ARG SER TYR GLY CYS ASN GLY SEQRES 6 C 212 GLY TYR PRO TRP SER ALA LEU GLN LEU VAL ALA GLN TYR SEQRES 7 C 212 GLY ILE HIS TYR ARG ASN THR TYR PRO TYR GLU GLY VAL SEQRES 8 C 212 GLN ARG TYR CYS ARG SER ARG GLU LYS GLY PRO TYR ALA SEQRES 9 C 212 ALA LYS THR ASP GLY VAL ARG GLN VAL GLN PRO TYR ASN SEQRES 10 C 212 GLU GLY ALA LEU LEU TYR SER ILE ALA ASN GLN PRO VAL SEQRES 11 C 212 SER VAL VAL LEU GLU ALA ALA GLY LYS ASP PHE GLN LEU SEQRES 12 C 212 TYR ARG GLY GLY ILE PHE VAL GLY PRO CYS GLY ASN LYS SEQRES 13 C 212 VAL ASP HIS ALA VAL ALA ALA VAL GLY TYR GLY PRO ASN SEQRES 14 C 212 TYR ILE LEU ILE LYS ASN SER TRP GLY THR GLY TRP GLY SEQRES 15 C 212 GLU ASN GLY TYR ILE ARG ILE LYS ARG GLY THR GLY ASN SEQRES 16 C 212 SER TYR GLY VAL CYS GLY LEU TYR THR SER SER PHE TYR SEQRES 17 C 212 PRO VAL LYS ASN MODRES 3LFY OCS A 25 CYS CYSTEINESULFONIC ACID MODRES 3LFY OCS C 25 CYS CYSTEINESULFONIC ACID HET OCS A 25 9 HET OCS C 25 9 HET SER A 213 6 HET ASN A 214 9 HET SER C 213 6 HET GLY C 214 4 HET ASN C 215 9 HETNAM OCS CYSTEINESULFONIC ACID HETNAM SER SERINE HETNAM ASN ASPARAGINE HETNAM GLY GLYCINE FORMUL 1 OCS 2(C3 H7 N O5 S) FORMUL 3 SER 2(C3 H7 N O3) FORMUL 4 ASN 2(C4 H8 N2 O3) FORMUL 6 GLY C2 H5 N O2 FORMUL 8 HOH *171(H2 O) HELIX 1 1 SER A 24 THR A 42 1 19 HELIX 2 2 SER A 49 ASP A 57 1 9 HELIX 3 3 TYR A 61 GLY A 65 5 5 HELIX 4 4 TYR A 67 TYR A 78 1 12 HELIX 5 5 ASN A 117 GLN A 128 1 12 HELIX 6 6 GLY A 138 LEU A 143 1 6 HELIX 7 7 GLY A 198 LEU A 202 5 5 HELIX 8 8 SER C 24 GLY C 43 1 20 HELIX 9 9 SER C 49 ASP C 57 1 9 HELIX 10 10 TYR C 61 GLY C 65 5 5 HELIX 11 11 TYR C 67 ALA C 76 1 10 HELIX 12 12 ARG C 96 LYS C 100 5 5 HELIX 13 13 ASN C 117 GLN C 128 1 12 HELIX 14 14 GLY C 138 TYR C 144 1 7 HELIX 15 15 GLY C 198 LEU C 202 5 5 SHEET 1 A 3 VAL A 5 ASP A 6 0 SHEET 2 A 3 HIS A 159 TYR A 166 -1 O TYR A 166 N VAL A 5 SHEET 3 A 3 VAL A 130 LEU A 134 -1 N VAL A 130 O ALA A 163 SHEET 1 B 5 VAL A 5 ASP A 6 0 SHEET 2 B 5 HIS A 159 TYR A 166 -1 O TYR A 166 N VAL A 5 SHEET 3 B 5 TYR A 170 LYS A 174 -1 O LYS A 174 N ALA A 162 SHEET 4 B 5 TYR A 186 LYS A 190 -1 O ILE A 187 N ILE A 173 SHEET 5 B 5 ILE A 148 PHE A 149 1 N PHE A 149 O LYS A 190 SHEET 1 C 2 VAL A 110 GLN A 112 0 SHEET 2 C 2 PHE A 207 PRO A 209 -1 O TYR A 208 N ARG A 111 SHEET 1 D 2 VAL C 5 ASP C 6 0 SHEET 2 D 2 GLY C 165 TYR C 166 -1 O TYR C 166 N VAL C 5 SHEET 1 E 2 GLY C 109 GLN C 112 0 SHEET 2 E 2 PHE C 207 VAL C 210 -1 O VAL C 210 N GLY C 109 SHEET 1 F 5 VAL C 130 LEU C 134 0 SHEET 2 F 5 HIS C 159 ALA C 163 -1 O ALA C 163 N VAL C 130 SHEET 3 F 5 ILE C 171 LYS C 174 -1 O LYS C 174 N ALA C 162 SHEET 4 F 5 TYR C 186 ILE C 189 -1 O ILE C 187 N ILE C 173 SHEET 5 F 5 ILE C 148 PHE C 149 1 N PHE C 149 O ARG C 188 SSBOND 1 CYS A 22 CYS A 63 1555 1555 2.02 SSBOND 2 CYS A 56 CYS A 95 1555 1555 2.02 SSBOND 3 CYS A 153 CYS A 200 1555 1555 2.02 SSBOND 4 CYS C 22 CYS C 63 1555 1555 2.02 SSBOND 5 CYS C 56 CYS C 95 1555 1555 2.02 SSBOND 6 CYS C 153 CYS C 200 1555 1555 2.03 LINK C SER A 24 N OCS A 25 1555 1555 1.33 LINK C OCS A 25 N TRP A 26 1555 1555 1.33 LINK C SER A 213 N ASN A 214 1555 1555 1.33 LINK C SER C 24 N OCS C 25 1555 1555 1.32 LINK C OCS C 25 N TRP C 26 1555 1555 1.33 LINK C SER C 213 N GLY C 214 1555 1555 1.33 LINK C GLY C 214 N ASN C 215 1555 1555 1.33 CISPEP 1 GLY A 151 PRO A 152 0 -0.03 CISPEP 2 GLY C 151 PRO C 152 0 -0.70 SITE 1 AC1 2 TRP A 177 ASN A 214 SITE 1 AC2 4 GLN A 142 TRP A 177 SER A 213 HOH A 296 SITE 1 AC3 6 GLN C 19 OCS C 25 ASP C 158 HIS C 159 SITE 2 AC3 6 TRP C 177 GLY C 214 SITE 1 AC4 4 GLY C 20 TRP C 177 SER C 213 ASN C 215 SITE 1 AC5 3 GLN C 142 TRP C 177 GLY C 214 CRYST1 48.890 48.890 200.870 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020454 0.011809 0.000000 0.00000 SCALE2 0.000000 0.023618 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004978 0.00000